The Potential Pathogenicity of Myelin Oligodendrocyte Glycoprotein Antibodies in the Optic Pathway.
Magdalena LerchAngelika BauerMarkus ReindlPublished in: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society (2022)
MOGAD patients often present with ON and harbor antibodies against MOG. Furthermore, pathogenesis is most likely a synergy between encephalitogenic T and antibody producing B cells. However, to which extent MOG-IgG are pathogenic and the exact pathologic mechanism is still not well understood.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- neoadjuvant chemotherapy
- squamous cell carcinoma
- optical coherence tomography
- risk assessment
- radiation therapy
- lymph node
- locally advanced
- staphylococcus aureus
- cystic fibrosis
- pseudomonas aeruginosa
- human health
- climate change
- candida albicans